NASDAQ:VYGR

Voyager Therapeutics Stock Predictions

etoro logo Buy VYGR
*Your capital is at risk
$3.60
+0.0100 (+0.279%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VYGR Prediction Chart

VYGR Predictions History

Latest community submissions for VYGR.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 13, 2025 $4.87 -2.63% $4.89 V 99.56% 5
Oct 13, 2025 $4.92 -1.64% $4.89 V 99.43% 4
Oct 13, 2025 Bearish $4.89 V 1
Oct 10, 2025 $5.02 -2.55% $5.00 V 99.63% 5
Oct 10, 2025 $5.07 -1.60% $5.00 V 98.64% 2
Oct 10, 2025 Bullish $5.00 X 0
Oct 7, 2025 $4.84 -2.21% $4.73 V 97.66% 1
Oct 7, 2025 $4.88 -1.38% $4.73 V 96.79% 1
Oct 7, 2025 Bullish $4.73 X 0
Oct 6, 2025 $4.75 -2.29% $4.95 X 95.93% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VYGR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VOYAGER THERAPEUTICS
Voyager Therapeutics
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE